On Monday, Legend Biotech Corp ADR (NASDAQ: LEGN) opened lower -3.33% from the last session, before settling in for the closing price of $33.62. Price fluctuations for LEGN have ranged from $31.20 to $70.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 59.11% over the last five years. Company’s average yearly earnings per share was noted 41.53% at the time writing. With a float of $181.93 million, this company’s outstanding shares have now reached $183.45 million.
The firm has a total of 1826 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.75%, operating margin of -53.92%, and the pretax margin is -66.41%.
Legend Biotech Corp ADR (LEGN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Legend Biotech Corp ADR is 0.83%, while institutional ownership is 49.53%. The most recent insider transaction that took place on Jan 10 ’25, was worth 72,553. Before that another transaction happened on Dec 24 ’24, when Company’s Officer proposed sale 63,061 for $32.45, making the entire transaction worth $2,046,512.
Legend Biotech Corp ADR (LEGN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.53% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Check out the current performance indicators for Legend Biotech Corp ADR (LEGN). In the past quarter, the stock posted a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.40 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Analysing the last 5-days average volume posted by the [Legend Biotech Corp ADR, LEGN], we can find that recorded value of 1.96 million was better than the volume posted last year of 1.66 million. As of the previous 9 days, the stock’s Stochastic %D was 26.26%. Additionally, its Average True Range was 2.26.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 7.91%, which indicates a significant decrease from 30.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.01% in the past 14 days, which was lower than the 50.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.25, while its 200-day Moving Average is $46.59. Now, the first resistance to watch is $33.76. This is followed by the second major resistance level at $35.03. The third major resistance level sits at $36.82. If the price goes on to break the first support level at $30.70, it is likely to go to the next support level at $28.91. Now, if the price goes above the second support level, the third support stands at $27.64.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
There are currently 182,634K shares outstanding in the company with a market cap of 5.96 billion. Presently, the company’s annual sales total 285,140 K according to its annual income of -518,250 K. Last quarter, the company’s sales amounted to 160,210 K and its income totaled -125,320 K.
